The 20 most frequent genomic alternations in CRC patients are shown in Figure 1(a), including TP53, APC, KRAS, PIK3CA, SMAD4, FBXW7, TCF7L2, and FAT4 with a frequency more than 10%. This evidence concerns the gene KRAS and colorectal carcinoma.